Yesterday, the Food and Drug Administration (FDA) began operating under the guidelines established in the most recent version of the Prescription Drug User Fee Act. PDUFA V was passed earlier this year by wide margins in the House and Senate as part of the Food and Drug Administration Reform Act of 2012, and was signed into law by President Obama on July 9th. CMM applauded the quick, bipartisan action on the bill and we were pleased with the final bill.
With the help of our thousands of supporters and our partner organizations like you, we worked to remind Congress why PDUFA was passed in the first place and how, if functioning as intended, it brings immense benefits to patients and the United States alike.
Our friends at PhRMA wrote a blog post today about "Day 1" of PDUFA V that details many of the important changes that PDUFA V brings to the FDA today and through the next five years. We encourage you to read it and learn more about why PDUFA V is critical to ensuring that patients will have access to the breakthrough cures and treatments they deserve, and that the U.S. can continue to lead the world in the discovery and delivery of cutting-edge medicines.